title: Long-term survival in an adolescent with widely metastatic renal cell carcinoma with rhabdoid features.
abstract: Renal cell carcinoma is rarely seen in children and adolescents. Patients with widespread disease at diagnosis have a particularly poor survival rate. Currently, all known chemotherapy has been ineffective in improving the median survival in patients with advanced disease. A 13-year-old black boy with stage IV renal cell carcinoma with rhabdoid features is a long-term disease-free survivor after aggressive multiagent chemotherapy. After the initial evaluation and histologic diagnosis of renal cell carcinoma, the patient received three courses of an aggressive chemotherapy regimen consisting of vincristine, doxorubicin, cyclophosphamide with mesna uroprotection, granulocyte colony-stimulating factor and erythropoietin (Epogen). After an almost complete response, a radical nephrectomy was performed and results demonstrated a solitary small nodule with viable tumor. After surgery, he received floxuridine infusion for 14 days by circadian schedule at 28-day intervals for a total of 1 year. The patient is well and free of disease 5 years after initial presentation. The dramatic response to treatment and long-term disease-free survival of this patient suggest this chemotherapeutic approach warrants additional investigation.
authors.affiliation: Division of Pediatric Hematology-Oncology, Saint Peter's University Hospital: Cancer Institute of New Jersey, New Brunswick 08903-0591, USA.
authors.forename: L J
authors.initials: LJ
authors.lastname: Ettinger
authors.forename: L A
authors.initials: LA
authors.lastname: Goodell
authors.forename: P
authors.initials: P
authors.lastname: Javidian
authors.forename: Y
authors.initials: Y
authors.lastname: Hsieh
authors.forename: P
authors.initials: P
authors.lastname: Amenta
mesh_terms: D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001707:Biopsy, Needle; D002292:Carcinoma, Renal Cell / Q000188:drug therapy / Q000401:mortality / Q000556:secondary*; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000473:pathology*; D008297:Male; D018335:Rhabdoid Tumor / Q000209:etiology; D017741:Survivors